Intellia Therapeutics, Inc.
NTLA
$13.42
-$0.06-0.45%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 449.88M | 511.04M | 459.65M | 503.75M | 601.52M |
| Total Receivables | 9.47M | 11.05M | 11.35M | 10.50M | 8.52M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 68.36M | 59.67M | 24.94M | 37.14M | 29.83M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 177.00K | -- | -- | -- |
| Total Current Assets | 527.71M | 581.94M | 495.95M | 551.39M | 639.86M |
|
|
|||||
| Total Current Assets | 527.71M | 581.94M | 495.95M | 551.39M | 639.86M |
| Net Property, Plant & Equipment | 123.63M | 138.30M | 151.85M | 163.10M | 246.67M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 13.08M | 16.69M | 54.16M | 43.57M | 17.39M |
| Total Assets | 842.13M | 925.28M | 898.89M | 986.16M | 1.19B |
|
|
|||||
| Total Accounts Payable | 20.25M | 13.26M | 9.80M | 12.36M | 14.59M |
| Total Accrued Expenses | 49.86M | 40.84M | 41.55M | 40.81M | 55.36M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 26.48M | 27.38M | 26.99M | 38.76M | 20.25M |
| Total Finance Division Other Current Liabilities | 7.29M | 12.25M | 17.15M | 20.66M | 20.66M |
| Total Other Current Liabilities | 7.29M | 12.25M | 17.15M | 20.66M | 20.66M |
| Total Current Liabilities | 103.88M | 93.73M | 95.50M | 112.59M | 110.85M |
|
|
|||||
| Total Current Liabilities | 103.88M | 93.73M | 95.50M | 112.59M | 110.85M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 66.85M | 70.59M | 75.60M | 80.49M | 189.95M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 12.54M | 12.54M | 13.16M | 18.26M |
| Total Liabilities | 170.73M | 176.85M | 183.64M | 206.24M | 319.06M |
|
|
|||||
| Common Stock & APIC | 3.26B | 3.24B | 3.11B | 3.07B | 3.05B |
| Retained Earnings | -2.59B | -2.49B | -2.39B | -2.29B | -2.18B |
| Treasury Stock & Other | 1.03M | 990.00K | 653.00K | 1.06M | 605.00K |
| Total Common Equity | 671.39M | 748.42M | 715.26M | 779.92M | 871.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 671.39M | 748.42M | 715.26M | 779.92M | 871.96M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 671.39M | 748.42M | 715.26M | 779.92M | 871.96M |
|
|
|||||